Acetylcholine-induced AMP-activated protein kinase activation attenuates vasoconstriction through an LKB1-dependent mechanism in rat aorta

Vascular Pharmacology

Volumn 59, Issue 3-4, 2013, Pages 96-102

  Lee, Kyung Young ^a   Choi, Hyoung Chul ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Acetylcholine (ACh); AMPK; LKB1; Vascular smooth muscle cell (VSMC)

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYLCHOLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MUSCARINIC RECEPTOR; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PHENYLEPHRINE; PROTEIN KINASE LKB1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CELLS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TENSION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

ACETYLCHOLINE (ACH); AMPK; LKB1; VASCULAR SMOOTH MUSCLE CELL (VSMC);

ACETYLCHOLINE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TIME FACTORS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 84885316381     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.07.007     Document Type: Article

References (32)

1. Agard C., Rolli-Derkinderen M., Dumas-de-La-Roque E., Rio M., Sagan C., Savineau J.P., et al. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol 2009, 158:1285-1294.
2. Bergner A., Sanderson M.J. Acetylcholine-induced calcium signaling and contraction of air way smooth muscle cells in lung slices. J Gen Physiol 2002, 119:187-198.
3. Cheng P.Y., Lee Y.M., Chung M.T., Shih Y.C., Yen M.H. Role of AMP-activated protein kinase in α-lipoic acid-induced vasodilatation in spontaneously hypertensive rats. Am J Hypertens 2012, 25:152-158.
4. Ewart M.A., Kennedy S. AMPK and vasculoprotection. Pharmacol Ther 2011, 131:242-253.
5. Funkushima S., Ohhashi T. Acetylcholine-induced endothelium-independent relaxations in monkey isolated superior and inferior caval veins. Br J Pharmacol 1993, 109:992-997.
6. Ford R.J., Rush J.W. Endothelium-dependent vasorelaxation to the AMPK activator AICAR is enhanced in aorta from hypertensive rats and is NO and EDCF dependent. Am J Physiol Heart Circ Physiol 2011, 300:H64-H75.
7. Green A.S., Chapuis N., Maciel T.T., Willems L., Lambert M., Arnoult C., et al. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. Blood 2010, 116:4262-4273.
8. Goirand F., Solar M., Athea Y., Viollet B., Mateo P., Fortin D., et al. Activation of AMP kinase alpha 1 subunit induces aortic vasorelaxation in mice. J Physiol 2007, 581:1163-1171.
9. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005, 280:29060-29066.
10. Harvey R.D. Muscarinic receptor agonists and antagonists: effects on cardiovascular function. Handb Exp Pharmacol 2012, 208:299-316.
11. Horman S., Morel N., Vertommen D., Hussain N., Neumann D., Beauloye C., et al. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J Biol Chem 2008, 283:18505-18512.
12. Hong F., Haldeman B.D., Jackson D., Carter M., Baker J.E., Cremo C.R. Biochemistry of smooth muscle myosin light chain kinase. Arch Biochem Biophys 2011, 510:135-146.
13. Ma Y., Yang F., Wang Y., Du Z., Liu D., Guo H., et al. CaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines. PLoS One 2012, 7:e47900.
14. Merlin J., Evans B.A., Csikasz R.I., Bengtsson T., Summers R.J., Hutchinson D.S. The M3-muscarinic acetylcholine receptor stimulates glucose. Cell Signal 2010, 22:1104-1111.
15. Namiki A., Aikawa J., Moroi M., Machii K., Akatsuka N. Acetylcholine-induced endothelium-dependent vascular smooth muscle relaxation in nitroglycerin-tolerant isolated rat aorta. Heart Vessels 1991, 6:175-180.
16. Richards O.C., Raines S.M., Attie A.D. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev 2010, 31:343-363.
17. 2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle. J Appl Physiol 2008, 104:1366-1373.
18. Spence V.A., Khan F., Kennedy G., Abbot N.C., Belch J.J. Acetylcholine mediated vasodilatation in the microcirculation of patients with chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids 2004, 70:403-407.
19. Shaw R.J. LKB1: Cancer, polarity, metabolism, and now fertility. Biochem J 2008, 416:e1-e3.
20. Spindel E.R. Muscarinic receptor agonists and antagonists: effects on cancer. Handb Exp Pharmacol 2012, 208:451-468.
21. Shah N., Khurana S., Cheng K., Raufman J.P. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 2009, 296:C221-C232.
22. Sung J.Y., Choi H.C. Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta. Biochem Biophys Res Commun 2012, 421:599-604.
23. Sung J.Y., Choi H.C. Aspirin-induced AMP-activated kinase activation regulates the proliferation of vascular smooth muscle cells from spontaneously hypertensive rats. Biochem Biophys Res Commun 2011, 408:312-317.
24. Sung J.Y., Woo C.H., Kang Y.J., Lee K.Y., Choi H.C. AMPK induces vascular smooth muscle cell senescence via LKB1 dependent pathway. Biochem Biophys Res Commun 2011, 413:143-148.
25. Thornton C., Sardini A., Carling D. Muscarinic receptor activation of AMP-activated protein kinase inhibits orexigenic neuropeptide mRNA expression. J Biol Chem 2008, 283:17116-17122.
26. Wang J., Krysiak P.S., Lauruer L.G., Sims S.M., Preiksaitis H.G. Human esophageal smooth muscle cells express muscarinic receptor subtypes M1 through M5. Am J Physiol Gastrointest Liver Physiol 2000, 279:G1059-G1069.
27. Watanabe H., Tran Q.K., Takeuchi K., Fukao M., Liu M.Y., Kanno M., et al. Myosin light-chain kinase regulates endothelial calcium entry and endothelium-dependent vasodilation. FASEB J 2000, 15:282-284.
28. Wang S., Liang B., Viollet B., Zou M.H. Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Hypertension 2011, 57:1010-1017.
29. Xie Z., Dong Y., Scholz R., Neumann D., Zou M.H. Phosphorylation of LKB1 at serine 428 by protein kinase c-ζ is required for metformin-enhanced activation of the amp-activated protein kinase in endothelial cells. Circulation 2008, 117:952-962.
30. Yamauchi T., Kamou J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
31. Zhou Y., Varadharaj S., Zhao X., Parinandi N., Flavahan N.A., Zweier J.L. Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 2005, 289:H1027-H1032.
32. Zou M.H., Wu Y. AMP-Activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol 2008, 35:535-545.